Quick search:
| Result | Content | Outlet | Published | Research |
|---|---|---|---|---|
| Result | Content | Outlet | Published | Research |
| 1 | Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose | Pfizer | 17 hours ago | |
| 2 | Pfizer and Moderna created life-saving vaccines. So why are their stocks crumbling? | CNN | 4 days ago | |
| 3 | Pfizer and BioNTech Submit Application for US Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age | Pfizer | 27 days ago | |
| 4 | Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission | Pfizer | 11 days ago | |
| 5 | Pfizer resisting Paxlovid requests for research supplies | FiercePharma | 4 days ago | |
| 6 | Pfizer loses top vaccine scientist Jansen who led drive for COVID-19 shot, searches for successor | FiercePharma | 25 days ago | |
| 7 | Pfizer partner Biovac warns of production slump amid low COVID vaccine demand: report | FiercePharma | 12 days ago | |
| 8 | Misinformation Proliferates Surrounding Pfizer Vaccine | Investopedia | 12 days ago | |
| 9 | Pfizer vaccine chief Kathrin Jansen, who led Covid effort, to retire | STAT | 25 days ago | |
| 10 | Pfizer did not 'hide' hiring of 2,400 people to handle expected increase of vaccine-related health | PolitiFact | 19 days ago | |
| 11 | Pfizer to Acquire Biohaven Pharmaceuticals | Pfizer | 14 days ago | |
| 12 | Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer at ESMO Breast Cancer 2022 | Pfizer | 20 days ago | |
| 13 | Pfizer's COVID Treatment Pill Falls Short | Investopedia | 19 days ago | |
| 14 | Pfizer Earnings and Revenue Soundly Beat Estimates, Though Paxlovid Sales Miss | Barron's | 21 days ago | |
| 15 | Pfizer hopes to submit little-kid vaccine data by early June | The Seattle Times | 21 days ago | |
| 16 | Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVID™ for Post-Exposure Prophylactic Use | Pfizer | 25 days ago | |
| 17 | Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11 | CNN | 28 days ago | |
| 18 | Pfizer’s Covid Vaccine Protection Against Omicron Fades Just Weeks After Second And Third Doses, Study Finds | Forbes | 11 days ago | |
| 19 | No, New Pfizer Docs Don't Show That Vaccines Are Unsafe During Pregnancy | Snopes.com | 18 days ago | |
| 20 | Covid-19: Campaign takes on Pfizer's “profiteering” | The BMJ | 21 days ago | |
| 21 | White House working to make Pfizer's Covid-19 antiviral pill more 'widely available' | CNN | 29 days ago | |
| 22 | Poland has no 'rationale to invoke force majeure in Pfizer vaccine deal, EU official says | Reuters | 22 days ago | |
| 23 | Moderna COVID vaccine may have slight edge over Pfizer in infections only | CIDRAP | 22 days ago | |
| 24 | Generic drugmakers to sell Pfizer's Paxlovid for $25 or less in low-income countries | Reuters | 12 days ago | |
| 25 | Pfizer recalls some batches of blood pressure drug over carcinogen presence | Reuters | 1 month ago | |
| 26 | Rare cases of COVID returning pose questions for Pfizer pill | The Associated Press | 15 days ago | |
| 27 | Pfzier's COVID-19 mRNA Booster Effectiveness Shot May Drop 3 Months In | Healthline | 29 days ago | |
| 28 | 'Wonderful' mother-of-two, 36, died from first dose of Covid Pfizer vaccine, inquest told | Daily Mail | 19 days ago | |
| 29 | Pfizer, CVS, Starbucks on Deck to Report Earnings in Coming Week | The Wall Street Journal | 24 days ago | |
| 30 | Did Johnson & Johnson's CFO Just Spell Trouble for Moderna and Pfizer? | The Motley Fool | 28 days ago | |
| 31 | Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age | Pfizer | 4 months ago | |
| 32 | FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age | FDA | FDA.gov | 7 months ago | |
| 33 | Pfizer and BioNTech Submit for US Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults | Pfizer | 2 months ago | |
| 34 | Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age | Pfizer | 1 month ago | |
| 35 | Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From US FDA | Pfizer | 4 months ago | |
| 36 | Pfizer and BioNTech Provide Update on Ongoing Studies of COVID-19 Vaccine | Pfizer | 5 months ago | |
| 37 | Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years | Pfizer | 8 months ago | |
| 38 | Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study | Pfizer | 7 months ago | |
| 39 | Pfizer and BioNTech Provide Update on Omicron Variant | Pfizer | 6 months ago | |
| 40 | Pfizer and BioNTech Receive Positive CHMP Opinion for COVID-19 Vaccine Booster in Adolescents 12 through 17 Years of Age in the European Union | Pfizer | 3 months ago | |
| 41 | Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11 | The New York Times | 7 months ago | |
| 42 | Pfizer says COVID-19 pill near 90% protective against hospitalization, death | Reuters | 5 months ago | |
| 43 | Manufacturing Sites: Made in the USA | Pfizer | 5 months ago | |
| 44 | Pfizer's peak COVID sales now pegged at $50B-plus, with vaccine still hauling in $25B by 2027: analysts | FiercePharma | 5 months ago | |
| 45 | Pfizer and BioNTech Receive US FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older | Pfizer | 5 months ago | |
| 46 | COVID tracker: AstraZeneca, Pfizer, Cepheid, Ocugen, more | FiercePharma | 1 month ago | |
| 47 | FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations | FDA | FDA.gov | 8 months ago | |
| 48 | Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases | Pfizer | 4 months ago | |
| 49 | Pfizer accused of pandemic profiteering as profits double | The Guardian | 3 months ago | |
| 50 | The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know | World Health Organization | 4 months ago | |
| 51 | Pfizer to Acquire Arena Pharmaceuticals | Pfizer | 5 months ago | |
| 52 | Pfizer revenue and profits soar on its Covid vaccine business | CNN | 7 months ago | |
| 53 | Pfizer Updates Company Position in Russia | Pfizer | 2 months ago | |
| 54 | Pfizer, BioNTech and Moderna making $1000 profit every second while world's poorest countries remain largely unvaccinated | World | 6 months ago | |
| 55 | Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full US FDA Approval for Individuals 16 Years and Older | Pfizer | 9 months ago | |
| 56 | Pfizer and BioNTech Receive Expanded US FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older | Pfizer | 6 months ago | |
| 57 | Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age | Pfizer | 6 months ago | |
| 58 | Pfizer says former employee stole trade secrets on megablockbuster COVID-19 vaccine | FiercePharma | 6 months ago | |
| 59 | FDA must hit the gas on FOIA request tied to Pfizer's COVID-19 vaccine, judge orders | FiercePharma | 5 months ago | |
| 60 | Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates | Pfizer | 2 months ago | |
| 61 | Pfizer to supply U.S. with 10 mln more courses of COVID-19 pills | Reuters | 5 months ago | |
| 62 | Pfizer to require U.S. workers receive COVID-19 vaccine or regular tests | Reuters | 10 months ago | |
| 63 | Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference | Pfizer | 3 months ago | |
| 64 | 'Betrayal of public trust': Pfizer under fire for resisting Paxlovid compulsory license | FiercePharma | 1 month ago | |
| 65 | Pfizer and BioNTech Expand Collaboration with US to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries | Pfizer | 8 months ago | |
| 66 | Pfizer's softly, softly, COVID marketing approach continues with new drug ad | FiercePharma | 2 months ago | |
| 67 | Pfizer's mix of science and grit alters the course of its COVID-19 response | McKinsey | 8 months ago | |
| 68 | In secret vaccine contracts with governments, Pfizer took hard line in push for profit, report says | The Washington Post | 7 months ago | |
| 69 | South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 | exec | 6 months ago | |
| 70 | Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential | Pfizer | 2 months ago | |
| 71 | Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries | Pfizer | 2 months ago | |
| 72 | Pfizer research head envisions a sprint to develop Omicron vaccine, if it's needed | STAT | 6 months ago | |
| 73 | Pfizer mRNA partner BioNTech reaped €19B last year but warns of lower prices in 2022 | FiercePharma | 2 months ago | |
| 74 | Generic drugmakers sign on to make cheap version of Pfizer COVID pill | Reuters | 2 months ago | |
| 75 | Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate | Pfizer | 6 months ago | |
| 76 | Pfizer Completes Acquisition of Arena Pharmaceuticals | Pfizer | 2 months ago | |
| 77 | Pfizer Announces New Chief Development Officer | Pfizer | 4 months ago | |
| 78 | High-flying Pfizer may disappoint on Comirnaty and Paxlovid sales in Q1, analyst warns | FiercePharma | 1 month ago | |
| 79 | Pfizer and BioNTech Announce Collaboration With Brazil's Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America | Pfizer | 9 months ago | |
| 80 | Pfizer's COVID pill Paxlovid gets boost in Britain thanks to spot in national trial | FiercePharma | 1 month ago | |
| 81 | Pfizer's Paxlovid contract with the government has some surprises : Shots | Health News | 4 months ago | |
| 82 | Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds | FDA | FDA.gov | 6 months ago | |
| 83 | Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply | Pfizer | 5 months ago | |
| 84 | Shot of a Lifetime: How Pfizer and BioNTech Developed and Manufactured a COVID-19 Vaccine in Record Time | Pfizer | 4 months ago | |
| 85 | Pfizer and BioNTech Announce Submission of Initial Data to US FDA to Support Booster Dose of COVID-19 Vaccine | Pfizer | 9 months ago | |
| 86 | Pfizer's Covid vaccine safe in people with prior myocarditis, study says | NBC News | 2 months ago | |
| 87 | Pfizer shot less effective in South Africa after Omicron emerges, study shows | Reuters | 5 months ago | |
| 88 | COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they're a double-edged sword for J&J and AZ | FiercePharma | 4 months ago | |
| 89 | Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults | Pfizer | 8 months ago | |
| 90 | Pfizer COVID vaccine study: Unvaccinated not swayed by FDA approval | USA TODAY | 2 months ago | |
| 91 | FDA Begins Releasing Pfizer COVID Vax Documents | Medpage Today | 3 months ago | |
| 92 | Pfizer inks $5.3B Paxlovid supply deal with US, adding to its huge pandemic revenue haul | FiercePharma | 6 months ago | |
| 93 | Pfizer Covid Vaccine Sales Boom and More to Know From Earnings | Barron's | 10 months ago | |
| 94 | Behind the scenes of the Pfizer COVID-19 vaccine | CBS News | 3 months ago | |
| 95 | AWS Helps Pfizer Accelerate Drug Development And Clinical Manufacturing | Pfizer | 6 months ago | |
| 96 | Pfizer takes the ax to US sales reps amid virtual push | FiercePharma | 4 months ago | |
| 97 | Moderna, Pfizer stocks fall as Covid omicron wave subsides in U.S. | CNBC | 3 months ago | |
| 98 | Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine | Pfizer | 5 months ago | |
| 99 | Pfizer offers a soft sell with a strong message on vaccines in first COVID ad | FiercePharma | 4 months ago | |
| 100 | Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine | CNN | 4 months ago |